MedTrace Logo

Patient Automated Text Hovering for IBD

NCT04388865 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-02-22

No results posted yet for this study

Summary

This is a 2-arm randomized trial aimed at leveraging behavioral science principles to improve patient engagement between office visits among patients with inflammatory bowel disease (IBD).

Conditions

Interventions

BEHAVIORAL

Control

Subjects will engage with their providers as is standard of care.

BEHAVIORAL

Text-based Clinical Hovering

Subjects will receive remote monitoring via text messaging of clinical symptoms and medication adherence reminders with feedback to social support.

Sponsors & Collaborators

Principal Investigators

  • Shivan Mehta, MD · University of Pennsylvania

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-23
Primary Completion
2023-01-10
Completion
2023-01-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04388865 on ClinicalTrials.gov